The Proclaim™ SCS Family, the Proclaim™ DRG System and the Infinity™ DBS platform support NeuroSphere™ Virtual Clinic allowing you to receive remote programming and go beyond clinical walls with the care and support you need. It’s the only DBS system available to offer remote programming technology helping you feel better, quicker.* The Infinity™ Deep Brain Stimulation system delivers mild pulses of electricity to the precise areas within the brain, alleviating symptoms of Parkinson’s and essential tremor. The Proclaim™ DRG Neurostimulation System is the first and only neurostimulation device approved only for complex regional pain syndrome (CRPS) and those seeking relief from causalgia -nerve pain following surgery or injury. Abbott’s SCS devices deliver its proprietary BurstDR™ stimulation waveform, a superior therapy designed to more closely mimic how pain signals travel to the brain and treat the emotional suffering related to pain, unlike traditional tonic stimulation. The Proclaim™ SCS Family and Eterna™ SCS System offer recharge-free and rechargeable options respectively, as well as an upgradeable software platform so patients can receive the latest technology without a replacement. The Proclaim™ SCS Family and Eterna™ SCS System are designed for the treatment of chronic pain, pain caused by Diabetic Peripheral Neuropathy, and non-surgical back pain. We can support you in your journey to reduce or stabilize the long-term use of medications and live life to the fullest. Undoubtedly, this proper selection and a better knowledge of its underlying mechanisms of action, will allow this cutting edge technique to be more acceptable among pain physicians.įailed back surgery syndrome indications neuromodulation review spinal cord stimulation.If you are living with chronic pain and movement disorders, our comprehensive portfolio of therapies can help you move and feel better by delivering stimulation to the spinal cord, dorsal root ganglion (DRG), or brain, depending on your needs. Spinal cord stimulation is a useful tool for neuromodulation, if an accurate patient selection is carried out prior, which should include a trial period. Further indications may be phantom limb pain, chronic intractable pain located in the head, face, neck, or upper extremities, spinal lumbar stenosis in patients who are not surgical candidates, and others. Also, this technique is useful in patients with refractory angina and critical limb ischemia, in whom surgical or endovascular treatment cannot be performed. Failed back surgery syndrome (FBSS) is the most common indication for SCS, whereas, the complex regional pain syndrome (CRPS) is the second one. At present, the indications of SCS are being revised constantly, while new applications are being proposed and researched worldwide. The mechanism of action of SCS would be based on the antidromic activation of the dorsal column fibers, which activate the inhibitory interneurons within the dorsal horn. In spite of the existence of several studies that try to prove the mechanism of action of SCS, it still remains unknown. This article is a non-systematic review of the mechanism of action, indications, results, programming parameters, complications, and cost-effectiveness of SCS. Following that, technological progress, among other advances, helped SCS become an effective tool to reduce pain. Spinal cord stimulation (SCS) has been used to treat neuropathic pain since 1967.